Business
India
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?
Symbiotec Pharmalab IPO enters its second day with 80% subscription and a 34% GMP, indicating strong listing expectations. The Rs 1,757 crore issue of…
NDTV News
The Hindu
News18 India
Hindustan Times